Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation

NCT02104297 is registered in ClinicalTrials.gov with Diskapi Yildirim Beyazit Education and Research Hospital as lead sponsor.

NCT NCT02104297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02104297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation
Lead sponsor
Diskapi Yildirim Beyazit Education and Research Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2014
Completion date
June 30, 2014
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agitation